Xiaoling Qiang

4.1k total citations · 1 hit paper
45 papers, 3.4k citations indexed

About

Xiaoling Qiang is a scholar working on Molecular Biology, Immunology and Clinical Biochemistry. According to data from OpenAlex, Xiaoling Qiang has authored 45 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Immunology and 14 papers in Clinical Biochemistry. Recurrent topics in Xiaoling Qiang's work include Immune Response and Inflammation (16 papers), Advanced Glycation End Products research (14 papers) and Neuropeptides and Animal Physiology (6 papers). Xiaoling Qiang is often cited by papers focused on Immune Response and Inflammation (16 papers), Advanced Glycation End Products research (14 papers) and Neuropeptides and Animal Physiology (6 papers). Xiaoling Qiang collaborates with scholars based in United States, Japan and China. Xiaoling Qiang's co-authors include Haichao Wang, Kevin J. Tracey, Jianhua Li, Ping Wang, Mahendar Ochani, Jesse Roth, Luis Ulloa, Huan Yang, Christopher J. Czura and Jan Andersson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Diabetes.

In The Last Decade

Xiaoling Qiang

43 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reversing established sepsis with antagonists of endogenous high-mobility group box 1

2003 942 citations Mahendar Ochani, Jianhua Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoling Qiang United States	23	1.2k	1.1k	1.1k	555	443	45	3.4k
Derek Strassheim United States	30	1.4k 1.2×	2.2k 1.9×	1.7k 1.6×	524 0.9×	436 1.0×	47	5.1k
Runkuan Yang United States	32	1.1k 1.0×	1.3k 1.1×	967 0.9×	648 1.2×	370 0.8×	50	3.9k
Teruto Hashiguchi Japan	36	636 0.5×	781 0.7×	1.1k 1.0×	437 0.8×	344 0.8×	131	4.0k
Michael Ombrellino United States	8	1.9k 1.6×	1.4k 1.3×	1.0k 0.9×	523 0.9×	219 0.5×	12	3.5k
Karin Palmblad Sweden	23	2.1k 1.8×	2.0k 1.7×	1.1k 1.0×	362 0.7×	262 0.6×	39	4.1k
Jaideep M. Vishnubhakat United States	7	1.9k 1.6×	1.5k 1.3×	984 0.9×	538 1.0×	228 0.5×	9	3.5k
Mohan R. Dasu United States	29	328 0.3×	1.1k 0.9×	781 0.7×	1.1k 1.9×	477 1.1×	39	3.2k
Hiroshi Obayashi Japan	33	405 0.3×	615 0.5×	672 0.6×	660 1.2×	721 1.6×	108	3.8k
Qiaobing Huang China	37	369 0.3×	645 0.6×	1.8k 1.7×	759 1.4×	663 1.5×	142	4.1k
Yuko Horii Japan	21	382 0.3×	928 0.8×	473 0.4×	259 0.5×	494 1.1×	46	2.9k

Countries citing papers authored by Xiaoling Qiang

Since Specialization

Citations

This map shows the geographic impact of Xiaoling Qiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Qiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Qiang more than expected).

Fields of papers citing papers by Xiaoling Qiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Qiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Qiang. The network helps show where Xiaoling Qiang may publish in the future.

Co-authorship network of co-authors of Xiaoling Qiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Qiang. A scholar is included among the top collaborators of Xiaoling Qiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Qiang. Xiaoling Qiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lou, et al.. (2025). Pro-Dermcidin as an Emerging Regulator of Innate Immunity in Sepsis. International Journal of Molecular Sciences. 26(15). 7643–7643.

Zhu, Shu, et al.. (2024). Elevated circulating procathepsin L as a potential biomarker of inflamm-aging. Medical Hypotheses. 186. 111322–111322. 1 indexed citations

Qiang, Xiaoling, Weiqiang Chen, Shu Zhu, et al.. (2024). Therapeutic potential of procathepsin L-inhibiting and progesterone-entrapping dimethyl-β-cyclodextrin nanoparticles in treating experimental sepsis. Frontiers in Immunology. 15. 1368448–1368448. 3 indexed citations

Li, Jianhua, et al.. (2023). A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis. Expert Opinion on Therapeutic Targets. 27(7). 575–591. 19 indexed citations

Zhu, Shu, Xiaoling Qiang, Jianhua Li, et al.. (2023). Identification of procathepsin L (pCTS-L)–neutralizing monoclonal antibodies to treat potentially lethal sepsis. Science Advances. 9(5). eadf4313–eadf4313. 14 indexed citations

Chen, Weiqiang, Shu Zhu, Xiaoling Qiang, et al.. (2023). Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis. International Journal of Molecular Sciences. 24(10). 8649–8649. 7 indexed citations

Qiang, Xiaoling, Jianhua Li, Shu Zhu, et al.. (2022). Human Dermcidin Protects Mice Against Hepatic Ischemia-Reperfusion–Induced Local and Remote Inflammatory Injury. Frontiers in Immunology. 12. 821154–821154. 9 indexed citations

Zhu, Shu, Xiaoling Qiang, Weiqiang Chen, et al.. (2021). Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review. Cells. 10(9). 2220–2220. 18 indexed citations

Qiang, Xiaoling, et al.. (2015). The in Vitro Immune-Modulating Properties of a Sweat Gland-Derived Antimicrobial Peptide Dermcidin. Shock. 45(1). 28–32. 17 indexed citations

10.

Chaung, Wayne, Rongqian Wu, Youxin Ji, et al.. (2011). Peripheral Administration of Human Adrenomedullin and Its Binding Protein Attenuates Stroke-Induced Apoptosis and Brain Injury in Rats. Molecular Medicine. 17(9-10). 1075–1083. 15 indexed citations

11.

Jacob, Asha, Rongqian Wu, Mian Zhou, et al.. (2011). Upregulation of Kupffer cell α2A-Adrenoceptors and downregulation of MKP-1 mediate hepatic injury in chronic alcohol exposure. Biochemical and Biophysical Research Communications. 409(3). 406–411. 14 indexed citations

12.

Wu, Rongqian, Weifeng Dong, Xiaoling Qiang, et al.. (2009). Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats*. Critical Care Medicine. 37(8). 2421–2426. 65 indexed citations

13.

Zhang, Fangming, Rongqian Wu, Xiaoling Qiang, Mian Zhou, & Ping Wang. (2009). Antagonism of α2A-adrenoceptor: a novel approach to inhibit inflammatory responses in sepsis. Journal of Molecular Medicine. 88(3). 289–296. 30 indexed citations

14.

Wu, Rongqian, Weifeng Dong, Xiaoling Qiang, et al.. (2008). Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock. Peptides. 29(7). 1223–1230. 11 indexed citations

15.

Qiang, Xiaoling, Rongqian Wu, Youxin Ji, Mian Zhou, & Ping Wang. (2008). Purification and Characterization of Human Adrenomedullin Binding Protein-1. Molecular Medicine. 14(7-8). 443–450. 10 indexed citations

16.

Guo-qian, Chen, Jianhua Li, Xiaoling Qiang, et al.. (2005). Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. Journal of Lipid Research. 46(4). 623–627. 101 indexed citations

17.

Li, Zhenguo, Xiaoling Qiang, Anders A. F. Sima, & George Grunberger. (2001). C-Peptide Attenuates Protein Tyrosine Phosphatase Activity and Enhances Glycogen Synthesis in L6 Myoblasts. Biochemical and Biophysical Research Communications. 280(3). 615–619. 47 indexed citations

18.

Grunberger, George, Xiaoling Qiang, Z. Li, et al.. (2001). Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia. 44(10). 1247–1257. 109 indexed citations

19.

Qiang, Xiaoling, Jo Satoh, Mikio Sagara, et al.. (1998). Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats. Metabolism. 47(8). 977–981. 39 indexed citations

20.

Takahashi, Kazuma, Jo Satoh, Mikio Sagara, et al.. (1995). Reduced Expression of c-Fos in Female NOD Mouse Thymocytes and Up-Regulation with Human Lymphotoxin. Cellular Immunology. 164(2). 287–294. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact